Selvita Future Growth

Future criteria checks 1/6

SelvitaDie Gewinne des Unternehmens werden voraussichtlich um 28.7% pro Jahr sinken, während die jährlichen Einnahmen um 17.4% pro Jahr steigen werden. Der Gewinn pro Aktie wird voraussichtlich decline um 32.4% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.9% betragen.

Key information

-28.7%

Earnings growth rate

-32.4%

EPS growth rate

Life Sciences earnings growth	20.9%
Revenue growth rate	17.4%
Future return on equity	13.9%
Analyst coverage	Low
Last updated	31 Mar 2024

Recent future growth updates

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 01

Recent updates

Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations

Apr 03

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 01

Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 22

Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?

Dec 25

Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?

Dec 02

Earnings and Revenue Growth Forecasts

WSE:SLV - Analysts future estimates and past financials data (PLN Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	500	41	14	68	3
12/31/2024	426	42	9	56	3
12/31/2023	352	70	5	79	N/A
9/30/2023	410	24	-20	65	N/A
6/30/2023	420	35	-32	72	N/A
3/31/2023	424	29	-50	56	N/A
12/31/2022	416	30	-25	75	N/A
9/30/2022	364	20	24	99	N/A
6/30/2022	351	11	28	85	N/A
3/31/2022	329	12	56	96	N/A
12/31/2021	316	15	60	85	N/A
9/30/2021	260	12	53	64	N/A
6/30/2021	216	18	29	46	N/A
3/31/2021	181	22	16	33	N/A
12/31/2020	142	18	14	29	N/A
9/30/2020	158	21	6	22	N/A
6/30/2020	99	15	N/A	N/A	N/A
3/31/2020	63	9	12	12	N/A
12/31/2019	54	7	4	6	N/A
9/30/2019	22	2	N/A	N/A	N/A
3/31/2019	81	10	-2	6	N/A
12/31/2018	77	10	4	12	N/A
12/31/2017	56	4	9	11	N/A

Analyst Future Growth Forecasts

Einkommen vs. Sparrate: SLVFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-28.7% pro Jahr).

Ertrag vs. Markt: SLVFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-28.7% pro Jahr).

Hohe Wachstumserträge: SLVFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: SLVDie Einnahmen des Unternehmens (16.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Polish (2.4% pro Jahr).

Hohe Wachstumseinnahmen: SLVDie Einnahmen des Unternehmens (17.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Earnings per Share Growth Forecasts

Future Return on Equity

Künftige Eigenkapitalrendite: SLVDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.4%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Selvita Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target decreased by 15% to zł70.18

Price target decreased by 11% to zł86.10

Recent updates

Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations

Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Selvita S.A. Launches Biologic Drug Discovery and Development Services

Price target decreased by 15% to zł70.18

Selvita S.A. to Report First Half, 2024 Results on Sep 25, 2024

Third quarter 2023 earnings released

Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially

We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt

First quarter 2023 earnings released

Selvita S.A., Annual General Meeting, Jun 27, 2023

Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors

Price target decreased by 11% to zł86.10

Selvita S.A. to Report Q3, 2023 Results on Nov 15, 2023

Now 21% undervalued

Selvita S.A. has completed a Follow-on Equity Offering in the amount of PLN 78.7 million.

Second quarter 2022 earnings released

Now 21% undervalued

Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly

Now 22% undervalued

Selvita S.A., Annual General Meeting, Jun 30, 2022

First quarter 2022 earnings: Revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well

Selvita Announces Management Changes

Third quarter 2021 earnings: Revenues exceed analyst expectations

Second quarter 2021 earnings released

First quarter 2021 earnings released

If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late

Investor sentiment improved over the past week

New 90-day high: zł63.20

Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like

Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential

New 90-day high: zł58.60

Selvita S.A. to Report Q1, 2021 Results on May 26, 2021

Investor sentiment improved over the past week

Selvita S.A. (WSE:SLV) completed the acquisition of Fidelta D.O.O. from Galapagos NV (ENXTAM:GLPG).

New 90-day high: zł49.30

Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?

Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?

Third quarter 2020 earnings released: EPS zł0.24

Selvita S.A. (WSE:SLV) signed an agreement to acquire 100% stake in Fidelta D.O.O. from Galapagos NV (ENXTAM:GLPG) for an enterprise value of €31.2 million.

New 90-day low: zł39.70

New 90-day low: zł41.40

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies